 |
Ratio, Inc is a biotechnology company developing a solution
for conveniently administering large molecule drugs such as insulin. |
| |
|
Ratio, Inc is a biotechnology company developing a solution
for conveniently administering large molecule drugs such as insulin. |

The technology was developed at the University of Wisconsin-Madison by
several inventors, notably Dr. Michael MacDonald and Dr. David Beebe. Ratio
was founded in 2005 by Tony Escarcega, a recent MBA graduate, and Dr.
Beebe. This technology has been patented by the Wisconsin Alumni
Research Foundation (WARF) and we have a license agreement with them. |
Our product is a disposable, adhesive drug delivery
pump worn on the skin. This device can be worn for up to 24 hours
and deliver a steady dose of drug, then it is discarded and a new patch
is applied. It is fully self-contained and is small in size (25mm
in diameter, 5mm thick), making it convenient to wear and easy to hide.
The key to this technology is the small non-electronic pump that allows
for constant dosing.
|

There are several competing products that can deliver large molecule
drugs; insulin pumps, needles, injector pens, and inhalers. Our product
is fundamentally different than these because it is small enough to be
attached to the skin and can deliver a steady dose of drug over time.
|